Literature DB >> 10995221

N-glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes.

O Barbier1, C Girard, R Breton, A Bélanger, D W Hum.   

Abstract

The recent cloning of several human and monkey UDP-glucuronosyltransferase (UGT) 2B proteins has allowed the characterization of these steroid metabolic enzymes. However, relatively little is known about the structure-function relationship, and the potential post-translational modifications of these proteins. The mammalian UGT2B proteins contain at least one consensus asparagine-linked glycosylation site NX(S/T). Endoglycosidase H digestion of the human and monkey UGT2B proteins demonstrates that only UGT2B7, UGT2B15, UGT2B17, and UGT2B20 are glycosylated. Although UGT2B15 and UGT2B20 contain three and four potential glycosylation sites, respectively, site-directed mutagenesis revealed that both proteins are glycosylated at the same first site. In both proteins, abolishing glycosylation decreased glucuronidation activity; however, the K(m) values and the substrate specificities were not affected. Despite the similarities between UGT2B15 and UGT2B20, UGT2B20 is largely more labile than UGT2B15. Treating HK293 cells stably expressing UGT2B20 with cycloheximide for 2 h decreased the enzyme activity by more than 50%, whereas the activity of UGT2B15 remained unchanged after 24 h. The UGT2B20 protein is unique in having an isoleucine at position 96 instead of an arginine as found in all the other UGT2B enzymes. Changing the isoleucine in UGT2B20 to an arginine stabilized enzyme activity, while the reciprocal mutation in UGT2B15 R96I produced a more labile enzyme. Secondary structure predictions of UGT2B proteins revealed a putative alpha-helix in this region in all the human and monkey proteins. This alpha-helix is shortest in UGT2B20; however, the helix is lengthened in UGT2B20 I96R. Thus, it is apparent that the length of the putative alpha-helix between residues 84 and 100 is a determining factor in the stability of UGT2B enzyme activity. This study reveals the extent and importance of protein glycosylation on UGT2B enzyme activity and that the effect of residue 96 on UGT2B enzyme stability is correlated to the length of a putative alpha-helix.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995221     DOI: 10.1021/bi000779p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver.

Authors:  Shogo J Miyagi; Abby C Collier
Journal:  Drug Metab Dispos       Date:  2011-01-25       Impact factor: 3.922

2.  Inhibition of human UGT2B7 gene expression in transgenic mice by the constitutive androstane receptor.

Authors:  M F Yueh; P L Mellon; R H Tukey
Journal:  Mol Pharmacol       Date:  2011-03-17       Impact factor: 4.436

3.  Cloning of UGT1A9 cDNA from liver tissues and its expression in CHL cells.

Authors:  X Li; Y N Yu; G J Zhu; Y L Qian
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  Placental profiling of UGT1A enzyme expression and activity and interactions with preeclampsia at term.

Authors:  Abby C Collier; Audrey D Thévenon; William Goh; Mark Hiraoka; Claire E Kendal-Wright
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-03       Impact factor: 2.441

5.  Molecular cloning of the baboon UDP-glucuronosyltransferase 2B gene family and their activity in conjugating morphine.

Authors:  Kirsten Abildskov; Piper Weldy; Marianne Garland
Journal:  Drug Metab Dispos       Date:  2010-01-13       Impact factor: 3.922

6.  Introduction of an N-Glycosylation Site into UDP-Glucuronosyltransferase 2B3 Alters Its Sensitivity to Cytochrome P450 3A1-Dependent Modulation.

Authors:  Tatsuro Nakamura; Naho Yamaguchi; Yuu Miyauchi; Tomoki Takeda; Yasushi Yamazoe; Kiyoshi Nagata; Peter I Mackenzie; Hideyuki Yamada; Yuji Ishii
Journal:  Front Pharmacol       Date:  2016-11-14       Impact factor: 5.810

7.  MOXD1 knockdown suppresses the proliferation and tumor growth of glioblastoma cells via ER stress-inducing apoptosis.

Authors:  Pengfei Shi; Jie Xu; Fanwei Xia; Yinggang Wang; Jie Ren; Ping Liang; Hongjuan Cui
Journal:  Cell Death Discov       Date:  2022-04-07

8.  Use of a Baculovirus-Mammalian Cell Expression-System for Expression of Drug-Metabolizing Enzymes: Optimization of Infection With a Focus on Cytochrome P450 3A4.

Authors:  Yuu Miyauchi; Akane Kimura; Madoka Sawai; Keiko Fujimoto; Yuko Hirota; Yoshitaka Tanaka; Shinji Takechi; Peter I Mackenzie; Yuji Ishii
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

9.  Androgen Glucuronidation in Mice: When, Where, and How.

Authors:  Laurent Grosse; Sarah Chouinard; Sophie Pâquet; Mélanie Verreault; Jocelyn Trottier; Alain Bélanger; Olivier Barbier
Journal:  Biology (Basel)       Date:  2022-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.